Patents by Inventor Ulrich Schopfer

Ulrich Schopfer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7741110
    Abstract: Single chain, monomeric polypeptide gene switches are provided. The gene switches include ligand binding domains and at least one functional domain. Preferred functional domains are DNA binding domains and transcriptional regulating domains. Methods of regulating gene function using the switches are also provided.
    Type: Grant
    Filed: November 15, 2005
    Date of Patent: June 22, 2010
    Assignee: The Scripps Research Institute
    Inventors: Carlos F. Barbas, III, Roger Beerli, Ulrich Schopfer
  • Publication number: 20060178502
    Abstract: Single chain, monomeric polypeptide gene switches are provided. The gene switches include ligand binding domains and at least one functional domain. Preferred functional domains are DNA binding domains and transcriptional regulating domains. Methods of regulating gene function using the switches are also provided.
    Type: Application
    Filed: November 15, 2005
    Publication date: August 10, 2006
    Applicant: The Scripps Research Institute
    Inventors: Carlos Barbas, Roger Beerli, Ulrich Schopfer
  • Patent number: 7045533
    Abstract: The present invention relates to novel naphthalene derivatives of formula (I), wherein R1, R2, R3 and X are as defined in the description, and preparation thereof. The compounds of formula (I) are useful as pharmaceuticals.
    Type: Grant
    Filed: November 22, 2001
    Date of Patent: May 16, 2006
    Assignee: Novartis AG
    Inventors: Christopher T Brain, Andrew J Culshaw, Edward K Dziadulewicz, Ulrich Schopfer
  • Patent number: 7011972
    Abstract: Single chain, monomeric polypeptide gene switches are provided. The gene switches include ligand binding domains and at least one functional domain. Preferred functional domains are DNA binding domains and transcriptional regulating domains. Methods of regulating gene function using the switches are also provided.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: March 14, 2006
    Assignee: The Scripps Research Institute
    Inventors: Carlos F. Barbas, III, Roger Beerli, Ulrich Schopfer
  • Publication number: 20040053890
    Abstract: The present invention relates to novel naphthalene derivatives of formula (I), wherein R1, R2, R3 and X are as defined in the description, and preparation thereof. The compounds of formula (I) are useful as pharmaceuticals.
    Type: Application
    Filed: May 19, 2003
    Publication date: March 18, 2004
    Inventors: Christopher Thomas Brain, Andrew James Culshaw, Edward Karol Dziadulewicz, Ulrich Schopfer
  • Publication number: 20020168714
    Abstract: Single chain, monomeric polypeptide gene switches are provided. The gene switches include ligand binding domains and at least one functional domain. Preferred functional domains are DNA binding domains and transcriptional regulating domains. Methods of regulating gene function using the switches are also provided.
    Type: Application
    Filed: July 18, 2001
    Publication date: November 14, 2002
    Applicant: The Scripps Research Institute
    Inventors: Carlos F. Barbas, Roger Beerli, Ulrich Schopfer